Open Access

[Retracted] Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy

  • Authors:
    • Liyu Chen
    • Yanbin Liu
    • Weiya Wang
    • Kai Liu
  • View Affiliations

  • Published online on: March 3, 2021     https://doi.org/10.3892/ol.2021.12611
  • Article Number: 350
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

May-2021
Volume 21 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen L, Liu Y, Wang W and Liu K: [Retracted] Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy. Oncol Lett 21: 350, 2021
APA
Chen, L., Liu, Y., Wang, W., & Liu, K. (2021). [Retracted] Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy. Oncology Letters, 21, 350. https://doi.org/10.3892/ol.2021.12611
MLA
Chen, L., Liu, Y., Wang, W., Liu, K."[Retracted] Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy". Oncology Letters 21.5 (2021): 350.
Chicago
Chen, L., Liu, Y., Wang, W., Liu, K."[Retracted] Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy". Oncology Letters 21, no. 5 (2021): 350. https://doi.org/10.3892/ol.2021.12611